ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow RMD
ResMed Inc. (RMD) Net income
ResMed Inc.'s net income for fiscal 2026 was $1.5B, up 8.75% from $1.4B in fiscal 2025. Over the past ten years it has ranged from $315.6M (fiscal 2018) to $1.5B (fiscal 2026) — the current reading is the highest in ten years. Net income has risen for 5 consecutive fiscal years. ResMed Inc. ranks 3rd of 54 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2026 | $1.5B | 8.75% |
| FY2025 | $1.4B | 37.20% |
| FY2024 | $1.0B | 13.75% |
| FY2023 | $897.6M | 15.15% |
| FY2022 | $779.4M | 64.26% |
| FY2021 | $474.5M | (23.67%) |
| FY2020 | $621.7M | 53.65% |
| FY2019 | $404.6M | 28.20% |
| FY2018 | $315.6M | (7.80%) |
| FY2017 | $342.3M | (2.87%) |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $383.4M | (3.84%) |
| Mar 2026 | $398.7M | 1.56% |
| Dec 2025 | $392.6M | 12.64% |
| Sep 2025 | $348.5M | (8.21%) |
| 42 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| MDLN Medline Inc. compare | $1.9B |
| RMD ResMed Inc. | $1.5B |
| SOLV Solventum Corporation compare | $1.4B |
| BDX Becton, Dickinson and Company compare | $942.0M |
| ALC Alcon compare | $643.0M |
| COO The Cooper Companies, Inc. compare | $570.3M |
| WST West Pharmaceutical Services, Inc. compare | $564.9M |
| RGEN Repligen Corporation compare | $41.5M |
| BAX Baxter International Inc. compare | −$1.1B |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on RMD
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement